Company Filing History:
Years Active: 2015
Title: Tomoki Suzuki: Innovator in IL-6 Targeting Aptamers
Introduction
Tomoki Suzuki is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of aptamers that target interleukin-6 (IL-6). His innovative work has implications for treating and diagnosing conditions mediated by IL-6.
Latest Patents
Tomoki Suzuki holds a patent for "Aptamers that bind to IL-6 and their use in treating or diagnosing IL-6 mediated conditions." This patent provides pharmaceutical compositions comprising IL-6 aptamers, as well as methods for treating conditions using these aptamers. His work in this area is groundbreaking and has the potential to impact various medical applications.
Career Highlights
Throughout his career, Tomoki Suzuki has worked with notable companies such as Somalogic, Incorporated and Otsuka Pharmaceutical Company, Limited. His experience in these organizations has allowed him to refine his expertise in biotechnology and contribute to significant advancements in the field.
Collaborations
Tomoki Suzuki has collaborated with esteemed colleagues, including Shashi Gupta and Masao Hirota. These partnerships have fostered a collaborative environment that enhances innovation and research in the biotechnology sector.
Conclusion
Tomoki Suzuki is a key figure in the development of IL-6 targeting aptamers, with a patent that showcases his innovative approach to biotechnology. His contributions to the field are noteworthy and continue to influence medical research and treatment strategies.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.